The Follow-up of Mesh/Native Tissue Complications Study(Part II)

NCT03617211 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1530

Last updated 2018-08-06

No results posted yet for this study

Summary

To study the incidence and distribution of complications after different pelvic reconstruction surgeries (mesh/native tissue) in multi-centers. The investigators aimed to report and summarize the postoperative complications diagnosed in the prior 1 year, 3 years and 5 years respectively, according to the International Urogynecological AssociationInternational Continence Society(IUGA-ICS) Complication Classification Coding(Category-Time-Site coding system) .

Conditions

  • Pelvic Organ Prolapse

Sponsors & Collaborators

  • Peking University People's Hospital

    collaborator OTHER
  • Qilu Hospital of Shandong University

    collaborator OTHER
  • Obstetrics & Gynecology Hospital of Fudan University,Shanghai Red House Obstetrics & Gynecology Hospital

    collaborator UNKNOWN
  • Peking University Third Hospital

    collaborator OTHER
  • First Hospitals affiliated to the China PLA General Hospital

    collaborator OTHER_GOV
  • Shanghai Jiao Tong University Affiliated Sixth People's Hospital

    collaborator OTHER
  • Tongji Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER
  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER
  • Wuxi Obsetrics & Gynecology Hospital

    collaborator UNKNOWN
  • Fuzhou General Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Jinan Hospital

    collaborator UNKNOWN
  • Women's Hospital School Of Medicine Zhejiang University

    collaborator OTHER
  • Renmin Hospital of Wuhan University

    collaborator OTHER
  • The Third Hospital Affiliated Zhengzhou University

    collaborator UNKNOWN
  • Shengjing Hospital

    collaborator OTHER
  • General Hospital of Ningxia Medical University

    collaborator OTHER
  • The Second Hospital of Hebei Medical University

    collaborator OTHER
  • Gansu Provincial Maternal and Child Health Care Hospital

    collaborator OTHER
  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER
  • Yantai Yuhuangding Hospital,Medical College, Qingdao University

    collaborator UNKNOWN
  • Southwest Hospital, China

    collaborator OTHER
  • West China Second University Hospital

    collaborator OTHER
  • Jiangxi Maternal and Child Health Hospital

    collaborator OTHER
  • Chongqing Medical University

    collaborator OTHER
  • Shanxi Coal Central Hospital

    collaborator UNKNOWN
  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Lan Zhu, MD · Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2023-06-30
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03617211 on ClinicalTrials.gov